David Charles Boettiger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
David Charles Boettiger has a total of 531 co-authors. Here are the top co-authors by number of shared publications:
Nagalingeswaran Kumarasamy
Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS) VHS‐Infectious Diseases Medical Centre, VHS Chennai India
14 shared publications- Romanee Chaiwarith
Faculty of Medicine and Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand
12 shared publications - Evy Yunihastuti
Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
11 shared publications Sasisopin Kiertiburanakul
Affiliation Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
11 shared publicationsJeremy Ross
TREAT Asia, amfAR—The Foundation for AIDS Research , Bangkok , Thailand
8 shared publications- Jun Yong Choi
Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
8 shared publications
Latest Publications
- Open Access
- 10 March 2026
- Published by Wolters Kluwer Health in Asia Pacific Allergy
- Vol. 16 (3) , 174-180
Tick bite prevention and management: integrating patient perspectives to shape patient education
Background: The rise in tick anaphylaxis (TA) in Australia and worldwide underscores the need for effective tick bite prevention and management strategies. Objectives: This retrospective survey of a clinical TA cohort aimed to determine prevention and management strategies employed by patients who had received education following diagnosis of TA and identify areas for improvement in patient education. Methods: Patients diagnosed with TA by a consultant immunologist between 2005 and 2021 in NSW, Australia, completed a survey in 2021 assessing tick bite recurrence, life stage identification, removal methods, need for medical assistance, prevention strategies, and geographic tick bite locations. Relationships between tick bite occurrence and prevention methods, such as the use of permethrin-treated clothing and backyard pest control, were analyzed with Kaplan–Meier curves and log-rank tests. Results: Despite receiving education at the time of their previous TA, 59% of patients experienced further tick bites, and 50% struggled to identify the tick life stage. Preferred prevention methods included avoidance, untreated clothing, and repellents, with some using backyard insecticides. We observed a trend towards reduced tick bite recurrence among patients who treated their backyards and wore permethrin-treated clothing. Almost 46% of bites occurred in patients’ backyards. Adherence to tick removal advice was highly variable. Only 30% of patients sought medical help when bitten again. Conclusion: The recurrence of tick bite in TA patients despite education at first diagnosis indicates a need for clearer and more frequent education to encourage adherence to prevention strategies, targeting high-risk groups, to prevent further fatalities.
- 10 March 2026
- Published by Wolters Kluwer Health in Asia Pacific Allergy
- Vol. 16 (3) , 174-180
Open AccessTick bite prevention and management: integrating patient perspectives to shape patient education
Background: The rise in tick anaphylaxis (TA) in Australia and worldwide underscores the need for effective tick bite prevention and management strategies. Objectives: This retrospective survey of a clinical TA cohort aimed to determine prevention and management strategies employed by patients who had received education following diagnosis of TA and identify areas for improvement in patient education. Methods: Patients diagnosed with TA by a consultant immunologist between 2005 and 2021 in NSW, Australia, completed a survey in 2021 assessing tick bite recurrence, life stage identification, removal methods, need for medical assistance, prevention strategies, and geographic tick bite locations. Relationships between tick bite occurrence and prevention methods, such as the use of permethrin-treated clothing and backyard pest control, were analyzed with Kaplan–Meier curves and log-rank tests. Results: Despite receiving education at the time of their previous TA, 59% of patients experienced further tick bites, and 50% struggled to identify the tick life stage. Preferred prevention methods included avoidance, untreated clothing, and repellents, with some using backyard insecticides. We observed a trend towards reduced tick bite recurrence among patients who treated their backyards and wore permethrin-treated clothing. Almost 46% of bites occurred in patients’ backyards. Adherence to tick removal advice was highly variable. Only 30% of patients sought medical help when bitten again. Conclusion: The recurrence of tick bite in TA patients despite education at first diagnosis indicates a need for clearer and more frequent education to encourage adherence to prevention strategies, targeting high-risk groups, to prevent further fatalities.
- Open Access
- 23 December 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (12) , e0005666
Assessing the impact of the COVID-19 pandemic on uptake of HIV treatment in Bandung and Yogyakarta, Indonesia: A retrospective cohort study
COVID-19 pandemic known to affect health service deliveries including for HIV care support and treatment. In this retrospective study involving 2,780 people living with HIV (PLHIV), we evaluated impact of COVID-19 pandemic by comparing the proportion of PLHIV linked to care, started antiretroviral therapy (ART), retained in care (within the first 3 months of treatment), and adhered to ART (within the first 3 months of treatment) between the pre-pandemic period (2018–2019) and pandemic period (2020–2021) in Yogyakarta and Bandung, Indonesia. Our study showed that during the pandemic period the number of PLHIV linked to care was 18% lower (1,529 vs 1,251) and those retained in care was significantly lower (59.6% vs 53.3%, p = 0.0009) than the pre-pandemic period. Whereas, proportion in ART initiation (79.6% vs 78.3%, p = 0.3892) and ART adherence (50.0% vs 46.8%, p = 0.1010) were not statistically different. Multivariate analysis showed that ART initiation (aOR = 1.00, p = 0.996) nor retention in care (aOR = 0.90, p = 0.344) were not significantly different between two period cohorts. Adherence for the first three months of treatment, however, was significantly higher in the pandemic cohort (aOR = 1.53, p = 0.009). In the subgroup analysis, older PLHIV and those attending hospitals (tertiary versus primary care clinics) were significantly less likely to initiate ART, be retained in care, or adhere to ART. This study provides evidence of the impact of the COVID-19 pandemic on several characteristics of the HIV treatment cascade such as lower number of linkage to- and retention in care, lower number of older PLHIV, and attendance to tertiary care (hospital). General and HIV-specific mitigation strategies should be designed to minimise pandemic related disruptions and to support the continuity of HIV care to face possible future health crises.
- 23 December 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (12) , e0005666
Open AccessAssessing the impact of the COVID-19 pandemic on uptake of HIV treatment in Bandung and Yogyakarta, Indonesia: A retrospective cohort study
COVID-19 pandemic known to affect health service deliveries including for HIV care support and treatment. In this retrospective study involving 2,780 people living with HIV (PLHIV), we evaluated impact of COVID-19 pandemic by comparing the proportion of PLHIV linked to care, started antiretroviral therapy (ART), retained in care (within the first 3 months of treatment), and adhered to ART (within the first 3 months of treatment) between the pre-pandemic period (2018–2019) and pandemic period (2020–2021) in Yogyakarta and Bandung, Indonesia. Our study showed that during the pandemic period the number of PLHIV linked to care was 18% lower (1,529 vs 1,251) and those retained in care was significantly lower (59.6% vs 53.3%, p = 0.0009) than the pre-pandemic period. Whereas, proportion in ART initiation (79.6% vs 78.3%, p = 0.3892) and ART adherence (50.0% vs 46.8%, p = 0.1010) were not statistically different. Multivariate analysis showed that ART initiation (aOR = 1.00, p = 0.996) nor retention in care (aOR = 0.90, p = 0.344) were not significantly different between two period cohorts. Adherence for the first three months of treatment, however, was significantly higher in the pandemic cohort (aOR = 1.53, p = 0.009). In the subgroup analysis, older PLHIV and those attending hospitals (tertiary versus primary care clinics) were significantly less likely to initiate ART, be retained in care, or adhere to ART. This study provides evidence of the impact of the COVID-19 pandemic on several characteristics of the HIV treatment cascade such as lower number of linkage to- and retention in care, lower number of older PLHIV, and attendance to tertiary care (hospital). General and HIV-specific mitigation strategies should be designed to minimise pandemic related disruptions and to support the continuity of HIV care to face possible future health crises.
- Open Access
- 18 December 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (4) , e1031-e1039
The Pandemic Respiratory Virus Epidemiological Surveillance Trial - A Self-swab Surveillance System for Respiratory Viruses Nested Within FluTracking
Background: The COVID-19 pandemic has underscored the importance of effective surveillance and early warning systems for respiratory viruses, but most current surveillance data focus on symptomatic individuals visiting healthcare facilities. Symptomatic and asymptomatic virus transmission in the community can both play major roles in the spread of respiratory outbreaks. We aimed to assess the feasibility of monitoring symptomatic and asymptomatic respiratory virus infection in a sample of community dwelling volunteers. Methods: The Pandemic Respiratory Virus Epidemiological SurveillaNce Trial was nested within the ongoing FluTracking platform, which involves community-dwelling adults filling in a weekly online respiratory symptom survey. We recruited 52 FluTracking participants living in one Australian city to self-collect weekly nasal swabs and return them via post for a 50-week period. All swabs were tested for the presence of respiratory viruses using a 16-plex PCR panel. Results were correlated with weekly symptom surveys. Results: A total of 2068 nasal swabs were received, corresponding to an 84% swab collection and return rate. Fifty-five samples (3.0%) were discarded due to delayed postage or sample leakage. At least one sample tested positive for virus in 231 of 2013 participant-weeks (11.0%), with 24.2% of these detections being in asymptomatic individuals. Rhinovirus (57.6% of positive swabs) and SARS-COV-2 (20.3% of positive swabs) were the most frequently detected viruses. Conclusions: Regular self-collected nasal swabs for detecting respiratory viruses in a community setting is feasible in Australia and provides valuable information on asymptomatic infection.
- 18 December 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (4) , e1031-e1039
Open AccessThe Pandemic Respiratory Virus Epidemiological Surveillance Trial - A Self-swab Surveillance System for Respiratory Viruses Nested Within FluTracking
Background: The COVID-19 pandemic has underscored the importance of effective surveillance and early warning systems for respiratory viruses, but most current surveillance data focus on symptomatic individuals visiting healthcare facilities. Symptomatic and asymptomatic virus transmission in the community can both play major roles in the spread of respiratory outbreaks. We aimed to assess the feasibility of monitoring symptomatic and asymptomatic respiratory virus infection in a sample of community dwelling volunteers. Methods: The Pandemic Respiratory Virus Epidemiological SurveillaNce Trial was nested within the ongoing FluTracking platform, which involves community-dwelling adults filling in a weekly online respiratory symptom survey. We recruited 52 FluTracking participants living in one Australian city to self-collect weekly nasal swabs and return them via post for a 50-week period. All swabs were tested for the presence of respiratory viruses using a 16-plex PCR panel. Results were correlated with weekly symptom surveys. Results: A total of 2068 nasal swabs were received, corresponding to an 84% swab collection and return rate. Fifty-five samples (3.0%) were discarded due to delayed postage or sample leakage. At least one sample tested positive for virus in 231 of 2013 participant-weeks (11.0%), with 24.2% of these detections being in asymptomatic individuals. Rhinovirus (57.6% of positive swabs) and SARS-COV-2 (20.3% of positive swabs) were the most frequently detected viruses. Conclusions: Regular self-collected nasal swabs for detecting respiratory viruses in a community setting is feasible in Australia and provides valuable information on asymptomatic infection.
- 10 September 2025
- Published by Elsevier in Annals of Epidemiology
- Vol. 110, 178-186
HIV incidence and associated risk factors among key populations accessing routine testing through the national health coverage system in Thailand: A nationwide real-world study
- 10 September 2025
- Published by Elsevier in Annals of Epidemiology
- Vol. 110, 178-186
HIV incidence and associated risk factors among key populations accessing routine testing through the national health coverage system in Thailand: A nationwide real-world study
- Open Access
- 10 September 2025
- Published by Oxford University Press (OUP) in Health Policy and Planning
- Vol. 40 (10) , 1102-1115
Understanding the financial hardships faced by TB and HIV patients during the COVID-19 pandemic: a mixed-method study in Bandung and Yogyakarta, Indonesia
The COVID-19 pandemic had significant widespread financial impacts, resulting in decreased household income, increased unemployment, and disrupted health services. Despite the higher prevalence of infections of tuberculosis (TB) and human immunodeficiency virus (HIV) in poorer populations, research on the financial challenges faced by these populations during the pandemic is still limited. Indonesia recorded the highest COVID-19 cases in Southeast Asia (6 815 156) while contending with the dual burden of HIV and TB. This study investigates the factors influencing out-of-pocket (OOP) payments and catastrophic health spending during the pandemic, alongside patients’ challenges and coping mechanisms in Bandung and Yogyakarta, Indonesia. We employed a parallel convergent mixed-methods approach, combining quantitative analysis of OOP costs with qualitative interviews. The determinants of OOP payments were analysed using a two-part cluster-robust regression model. Catastrophic health spending was defined as OOP payments exceeding 10% of a household’s annual income. Data on OOP spending were recorded via diaries, while qualitative data were gathered from in-depth interviews with TB and HIV patients and healthcare workers from January to October 2022. The findings indicated that 5.13% [95% confidence interval (CI): 2.99–7.28] of households incurred catastrophically. The median household spent USD 8.48 OOP, with nonmedical expenses comprising the largest share (median USD 5.93). Key predictors of higher costs included facility location in Yogyakarta (OOP costs difference USD 23.84, 95% CI: 9.90–37.77, P < .001), seeking care from public hospitals (USD 17.37, 95% CI: 8.83–25.90, P < .001), and the absence of health insurance (USD 10.49, 95% CI: 2.40–18.58, P = .011). Patients reported that job losses during lockdowns exacerbated financial strain, while coping strategies documented included borrowing, family contributions, and selling assets. This is the first study to focus on OOP spending and the financial hardships experienced by TB and HIV patients in Indonesia during the pandemic, providing insights for targeted policy and preparedness efforts to alleviate the financial burden during large-scale public health crises.
- 10 September 2025
- Published by Oxford University Press (OUP) in Health Policy and Planning
- Vol. 40 (10) , 1102-1115
Open AccessUnderstanding the financial hardships faced by TB and HIV patients during the COVID-19 pandemic: a mixed-method study in Bandung and Yogyakarta, Indonesia
The COVID-19 pandemic had significant widespread financial impacts, resulting in decreased household income, increased unemployment, and disrupted health services. Despite the higher prevalence of infections of tuberculosis (TB) and human immunodeficiency virus (HIV) in poorer populations, research on the financial challenges faced by these populations during the pandemic is still limited. Indonesia recorded the highest COVID-19 cases in Southeast Asia (6 815 156) while contending with the dual burden of HIV and TB. This study investigates the factors influencing out-of-pocket (OOP) payments and catastrophic health spending during the pandemic, alongside patients’ challenges and coping mechanisms in Bandung and Yogyakarta, Indonesia. We employed a parallel convergent mixed-methods approach, combining quantitative analysis of OOP costs with qualitative interviews. The determinants of OOP payments were analysed using a two-part cluster-robust regression model. Catastrophic health spending was defined as OOP payments exceeding 10% of a household’s annual income. Data on OOP spending were recorded via diaries, while qualitative data were gathered from in-depth interviews with TB and HIV patients and healthcare workers from January to October 2022. The findings indicated that 5.13% [95% confidence interval (CI): 2.99–7.28] of households incurred catastrophically. The median household spent USD 8.48 OOP, with nonmedical expenses comprising the largest share (median USD 5.93). Key predictors of higher costs included facility location in Yogyakarta (OOP costs difference USD 23.84, 95% CI: 9.90–37.77, P < .001), seeking care from public hospitals (USD 17.37, 95% CI: 8.83–25.90, P < .001), and the absence of health insurance (USD 10.49, 95% CI: 2.40–18.58, P = .011). Patients reported that job losses during lockdowns exacerbated financial strain, while coping strategies documented included borrowing, family contributions, and selling assets. This is the first study to focus on OOP spending and the financial hardships experienced by TB and HIV patients in Indonesia during the pandemic, providing insights for targeted policy and preparedness efforts to alleviate the financial burden during large-scale public health crises.
- Open Access
- 15 August 2025
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 99 (5) , 443-448
Brief Report: Retention and Viral Suppression With Differentiated Time or Space for Adolescent and Young Adult HIV Care: A Systematic Review and Meta-Analysis
Introduction: Adolescents and young adults living with HIV (AYAWH) encounter unique barriers affecting their adherence to treatment and overall health outcomes. Differentiated care for AYAWH has been suggested as a strategy to improve treatment outcomes for this demographic. This study evaluated the evidence on antiretroviral treatment outcomes of a differentiated care model with designated space or service time for AYAWH. Methods: A systematic review and meta-analysis were conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A literature search was conducted using PubMed and Embase and included peer-reviewed articles published in English. Articles comparing retention and viral suppression rates at differentiated adolescent or young adult-specific services with those at local standards of care facilities were included in the analysis. Differentiated care encompassed separate spaces (such as dedicated rooms or buildings) or operating hours designated exclusively for AYAWH. A random-effects meta-analysis was conducted to generate pooled risk ratios to evaluate the effectiveness of these tailored care models. Results: We identified 11 eligible articles, 10 of which from resource-limited settings in Africa. The meta-analysis revealed that differentiated time or space care for AYAWH significantly increases rates of retention (pooled RR 1.19, 95% CI: 1.13 to 1.26) and viral suppression (pooled RR 1.11, 95% CI: 1.05 to 1.17) among AYAWH, although moderate heterogeneity was observed in both outcomes (I2 of 69.5% and 57.3% for retention and viral suppression, respectively). Conclusion: Implementation of differentiated time or space for adolescent and young adult HIV care significantly improves retention and viral suppression rates among AYAWH.
- 15 August 2025
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 99 (5) , 443-448
Open AccessBrief Report: Retention and Viral Suppression With Differentiated Time or Space for Adolescent and Young Adult HIV Care: A Systematic Review and Meta-Analysis
Introduction: Adolescents and young adults living with HIV (AYAWH) encounter unique barriers affecting their adherence to treatment and overall health outcomes. Differentiated care for AYAWH has been suggested as a strategy to improve treatment outcomes for this demographic. This study evaluated the evidence on antiretroviral treatment outcomes of a differentiated care model with designated space or service time for AYAWH. Methods: A systematic review and meta-analysis were conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A literature search was conducted using PubMed and Embase and included peer-reviewed articles published in English. Articles comparing retention and viral suppression rates at differentiated adolescent or young adult-specific services with those at local standards of care facilities were included in the analysis. Differentiated care encompassed separate spaces (such as dedicated rooms or buildings) or operating hours designated exclusively for AYAWH. A random-effects meta-analysis was conducted to generate pooled risk ratios to evaluate the effectiveness of these tailored care models. Results: We identified 11 eligible articles, 10 of which from resource-limited settings in Africa. The meta-analysis revealed that differentiated time or space care for AYAWH significantly increases rates of retention (pooled RR 1.19, 95% CI: 1.13 to 1.26) and viral suppression (pooled RR 1.11, 95% CI: 1.05 to 1.17) among AYAWH, although moderate heterogeneity was observed in both outcomes (I2 of 69.5% and 57.3% for retention and viral suppression, respectively). Conclusion: Implementation of differentiated time or space for adolescent and young adult HIV care significantly improves retention and viral suppression rates among AYAWH.
- Open Access
- 21 January 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (1) , e0004172
Mortality among 5 to 19-year-olds in rural Mali
The unique healthcare needs of 5 to 9-year-olds and adolescents (10–19 years) in low- and middle-income countries have been largely neglected. We generated estimates of 5 to 9-year-old and adolescent mortality in rural Mali, a setting with high under-five mortality, and aimed to define associated individual and household risk factors. We analysed cross-sectional baseline household survey data from the ProCCM trial (NCT02694055) conducted in Bankass District, Mali collected in December 2016 and January 2017. Deaths in the preceding five years, household information, and women’s birth histories were documented. Factors associated with 5 to 9-year-old and adolescent mortality were analysed using Cox regression. Our study population comprised 23,485 children aged 5 to 9-years-old and 17,910 adolescents from 7,720 households. The 5 to 9-year-old and adolescent mortality rates were 3.10 and 1.90 deaths per 1,000 person-years, respectively. Mortality rates were similar among males and females aged 5 to 9 years, but grew increasingly divergent in adolescence (1.69 and 2.17 per 1,000 person-years, respectively). Five to 9-year-olds in households with untreated water had a higher risk of death than those in households with treated water. Adolescents living in the poorest households had a higher risk of death than those in the wealthiest, and adolescents in households in which no women received schooling had a higher risk of death than those in which women had some schooling. The risk of mortality was especially acute among female adolescents compared to their male counterparts, with low access to education for women being a strong contributing factor.
- 21 January 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (1) , e0004172
Open AccessMortality among 5 to 19-year-olds in rural Mali
The unique healthcare needs of 5 to 9-year-olds and adolescents (10–19 years) in low- and middle-income countries have been largely neglected. We generated estimates of 5 to 9-year-old and adolescent mortality in rural Mali, a setting with high under-five mortality, and aimed to define associated individual and household risk factors. We analysed cross-sectional baseline household survey data from the ProCCM trial (NCT02694055) conducted in Bankass District, Mali collected in December 2016 and January 2017. Deaths in the preceding five years, household information, and women’s birth histories were documented. Factors associated with 5 to 9-year-old and adolescent mortality were analysed using Cox regression. Our study population comprised 23,485 children aged 5 to 9-years-old and 17,910 adolescents from 7,720 households. The 5 to 9-year-old and adolescent mortality rates were 3.10 and 1.90 deaths per 1,000 person-years, respectively. Mortality rates were similar among males and females aged 5 to 9 years, but grew increasingly divergent in adolescence (1.69 and 2.17 per 1,000 person-years, respectively). Five to 9-year-olds in households with untreated water had a higher risk of death than those in households with treated water. Adolescents living in the poorest households had a higher risk of death than those in the wealthiest, and adolescents in households in which no women received schooling had a higher risk of death than those in which women had some schooling. The risk of mortality was especially acute among female adolescents compared to their male counterparts, with low access to education for women being a strong contributing factor.
- Open Access
- 2 January 2025
- Published by Wiley in Journal of the International AIDS Society
- Vol. 28 (1) , e26406
The impact of same‐day and rapid ART initiation under the Universal Health Coverage programme on HIV outcomes in Thailand: a retrospective real‐life cohort study
Introduction: Antiretroviral therapy (ART) initiation, regardless of CD4 count, has been recommended in Thailand since 2014, with same‐day initiation recommended since 2021. We assessed HIV treatment outcomes among Thai people living with HIV (PLHIV) by the time from HIV diagnosis to ART initiation under the Universal Health Coverage (UHC) programme and identified factors associated with virological failure (VF).Methods: PLHIV aged ≥15 years initiating ART between 2014 and 2022 were included from the UHC database. We categorized participants into four groups using the duration from HIV diagnosis to ART initiation: (1) ≤ 7 days (same‐day ART); (2) 8 days to 3 months. Viral load (VL) was measured 6 months after starting ART, and annually thereafter. VF was defined as VL ≥1000 copies/ml. Factors associated with VF were analysed using competing risk models considering death and loss to follow‐up (LTFU) as competing events.Results: Among 252,239 PLHIV who started ART, the median age at initiation was 34 years (interquartile range [IQR]: 26–43 years). The median (IQR) pre‐ART CD4 count was 233 (76–420) cells/mm3. ART initiation occurred within 7 days for 25% (17% on the same day, 8% in 2–7 days), 24% in 8 days to 3 months. ART initiation within 7 days increased from 20% (2014–2016) to 32% (2021–2022). VF occurred with a rate of 3.11 (95% CI 3.07–3.159) per 100 person‐years (PYs). PLHIV initiating ART 8 days to 1 month were at lower risk of VF (aSHR 0.52, 95% CI 0.50–0.54) when compared to ART initiation >3 months. ART initiation within 7 days resulted in the lowest mortality (6%: 1.28 [95% CI 1.24–1.32] per 100 PYs), but the highest rate of LTFU (12%: 2.69 [95% CI 2.63–2.75] per 100 PYs) when compared to other ART initiation groups.Conclusions: Although ART initiation within 7 days has increased in Thailand, the overall rate of early initiation remains low. ART initiation within 1 month significantly lowered the risk of VF. ART initiation within 7 days significantly reduced mortality. To further optimize health outcomes, innovative strategies are urgently needed to promote earlier ART initiation in Thailand.
- 2 January 2025
- Published by Wiley in Journal of the International AIDS Society
- Vol. 28 (1) , e26406
Open AccessThe impact of same‐day and rapid ART initiation under the Universal Health Coverage programme on HIV outcomes in Thailand: a retrospective real‐life cohort study
Introduction: Antiretroviral therapy (ART) initiation, regardless of CD4 count, has been recommended in Thailand since 2014, with same‐day initiation recommended since 2021. We assessed HIV treatment outcomes among Thai people living with HIV (PLHIV) by the time from HIV diagnosis to ART initiation under the Universal Health Coverage (UHC) programme and identified factors associated with virological failure (VF).Methods: PLHIV aged ≥15 years initiating ART between 2014 and 2022 were included from the UHC database. We categorized participants into four groups using the duration from HIV diagnosis to ART initiation: (1) ≤ 7 days (same‐day ART); (2) 8 days to 3 months. Viral load (VL) was measured 6 months after starting ART, and annually thereafter. VF was defined as VL ≥1000 copies/ml. Factors associated with VF were analysed using competing risk models considering death and loss to follow‐up (LTFU) as competing events.Results: Among 252,239 PLHIV who started ART, the median age at initiation was 34 years (interquartile range [IQR]: 26–43 years). The median (IQR) pre‐ART CD4 count was 233 (76–420) cells/mm3. ART initiation occurred within 7 days for 25% (17% on the same day, 8% in 2–7 days), 24% in 8 days to 3 months. ART initiation within 7 days increased from 20% (2014–2016) to 32% (2021–2022). VF occurred with a rate of 3.11 (95% CI 3.07–3.159) per 100 person‐years (PYs). PLHIV initiating ART 8 days to 1 month were at lower risk of VF (aSHR 0.52, 95% CI 0.50–0.54) when compared to ART initiation >3 months. ART initiation within 7 days resulted in the lowest mortality (6%: 1.28 [95% CI 1.24–1.32] per 100 PYs), but the highest rate of LTFU (12%: 2.69 [95% CI 2.63–2.75] per 100 PYs) when compared to other ART initiation groups.Conclusions: Although ART initiation within 7 days has increased in Thailand, the overall rate of early initiation remains low. ART initiation within 1 month significantly lowered the risk of VF. ART initiation within 7 days significantly reduced mortality. To further optimize health outcomes, innovative strategies are urgently needed to promote earlier ART initiation in Thailand.
- Open Access
- 4 June 2024
- Published by Elsevier in CMI Communications
- Vol. 1 (1)
Gut colonisation with extended-spectrum beta-lactamase producing Enterobacteriaceae in vegetarians: A systematic review and meta-analysis
- 4 June 2024
- Published by Elsevier in CMI Communications
- Vol. 1 (1)
Open AccessGut colonisation with extended-spectrum beta-lactamase producing Enterobacteriaceae in vegetarians: A systematic review and meta-analysis
- Open Access
- 16 May 2024
- Published by BMJ in BMJ Global Health
- Vol. 9 (5) , e014943
“I pity the TB patient”: a mixed methods study assessing the impact of the COVID-19 pandemic on TB services in two major Indonesian cities and distilling lessons for the future
Introduction In Indonesia, a country with around 280 million people and the second-highest tuberculosis (TB) incidence rate in the world, the impact of the COVID-19 pandemic on TB care needs careful assessment so that future response strategies can be strengthened. We conducted a study comparing TB testing and treatment rates before and during the first 2 years of the COVID-19 pandemic in Indonesia, and the reasons for any disruptions to care. Methods We conducted retrospective secondary data analysis and qualitative interviews in Yogyakarta and Bandung, Indonesia. Routine data on TB testing and treatment were sourced from the national TB information system operated by the Indonesian Ministry of Health. TB testing and treatment outcomes were compared between two time periods: pre-COVID (2018–19); and during COVID-19 (2020–21). In-depth interviews were conducted with patients and health workers to explore their experiences in accessing and providing TB services during the pandemic. Results There was a 45% (21 937/39 962) reduction in the number of patients tested for TB during the pandemic compared with pre-COVID-19, while the proportion of TB tests returning a positive result increased from 12% (4733/39 962) to 50% (10 945/21 937). The proportion of TB patients completing treatment increased by 2.6% during the pandemic, yet the proportion cured and the number of patients successfully treated both decreased (by 7% and 4.4%, respectively). Our qualitative interviews highlighted several factors influencing TB service access and delivery, including fear of being diagnosed with COVID-19 during TB-related clinic visits, fear of COVID-19 exposure among patients and health workers, healthcare facilities prioritising COVID-19 over other services, and mandatory mobility restrictions affecting both patients and health workers. Conclusion The COVID-19 pandemic impacted TB testing and treatment outcomes in Bandung and Yogyakarta. Policymakers should consider these findings in designing strategies to ensure TB services are maintained and supported during future health crises.
- 16 May 2024
- Published by BMJ in BMJ Global Health
- Vol. 9 (5) , e014943
Open Access“I pity the TB patient”: a mixed methods study assessing the impact of the COVID-19 pandemic on TB services in two major Indonesian cities and distilling lessons for the future
Introduction In Indonesia, a country with around 280 million people and the second-highest tuberculosis (TB) incidence rate in the world, the impact of the COVID-19 pandemic on TB care needs careful assessment so that future response strategies can be strengthened. We conducted a study comparing TB testing and treatment rates before and during the first 2 years of the COVID-19 pandemic in Indonesia, and the reasons for any disruptions to care. Methods We conducted retrospective secondary data analysis and qualitative interviews in Yogyakarta and Bandung, Indonesia. Routine data on TB testing and treatment were sourced from the national TB information system operated by the Indonesian Ministry of Health. TB testing and treatment outcomes were compared between two time periods: pre-COVID (2018–19); and during COVID-19 (2020–21). In-depth interviews were conducted with patients and health workers to explore their experiences in accessing and providing TB services during the pandemic. Results There was a 45% (21 937/39 962) reduction in the number of patients tested for TB during the pandemic compared with pre-COVID-19, while the proportion of TB tests returning a positive result increased from 12% (4733/39 962) to 50% (10 945/21 937). The proportion of TB patients completing treatment increased by 2.6% during the pandemic, yet the proportion cured and the number of patients successfully treated both decreased (by 7% and 4.4%, respectively). Our qualitative interviews highlighted several factors influencing TB service access and delivery, including fear of being diagnosed with COVID-19 during TB-related clinic visits, fear of COVID-19 exposure among patients and health workers, healthcare facilities prioritising COVID-19 over other services, and mandatory mobility restrictions affecting both patients and health workers. Conclusion The COVID-19 pandemic impacted TB testing and treatment outcomes in Bandung and Yogyakarta. Policymakers should consider these findings in designing strategies to ensure TB services are maintained and supported during future health crises.